Skip to main content
International Journal of Biomedical Science : IJBS logoLink to International Journal of Biomedical Science : IJBS
. 2015 Jun;11(2):61–66.

Serosurvey of Entamoeba Histolytica Exposure among Tepehuanos Population in Durango, Mexico

Cosme Alvarado-Esquivel 1, Jesús Hernández-Tinoco 2, Luis Francisco Sánchez-Anguiano 2, Agar Ramos-Nevárez 3, Sandra Margarita Cerrillo-Soto 3, Carlos Alberto Guido-Arreola 3
PMCID: PMC4502734  PMID: 26199578

Abstract

The seroepidemiology of Entamoeba histolytica infection in Tepehuanos population in Mexico is largely unknown. This study aimed to study the seroprevalence and correlates of E. histolytica antibodies in Tepehuanos in Durango, Mexico. Through a cross-sectional study, we determined the frequency of E. histolytica IgG antibodies in 156 Tepehuanos people in Durango, Mexico using an enzyme-linked immunoassay. Furthermore, we studied the association of E. histolytica seroprevalence with the socio-demographic, clinical, and behavioral characteristics of the Tepehuanos studied. Forty-four (28.2%) Tepehuanos with mean age of 31.03 ± 16.71 years old had anti- E. histolytica IgG antibodies. Multivariate analysis showed that E. histolytica exposure was positively associated with laborer occupation (Odds ratio=2.77; 95% CI: 1.15, 6.66; p=0.02), and history of lymphadenopathy (Odds ratio=4.97; 95% CI: 1.74, 14.13; p=0.002), and negatively associated with soil contact (Odds ratio=0.13; 95% CI: 0.03, 0.53; p=0.004). Other behavioral characteristics including drinking untreated water or unpasteurized milk, and consumption of unwashed raw vegetables or fruits were not associated with E. histolytica exposure. The seroprevalence of E. histolytica infection in Tepehuanos in Durango is higher thanseroprevalences reported in national surveys. The factors associated with E. histolytica seropositivity reported in the present study might aid for the planning and implementation of effective measures against E. histolytica infection.

Keywords: Entamoeba histolytica, seroepidemiologic studies, Tepehuanos, risk factors, Mexico

INTRODUCTION

Entamoeba histolytica is a protozoan parasite that causes morbidity and mortality in humans all around the world (1-3). Infection with E. histolytica predominates in the developing world where represents an important health problem (4, 5). A major transmission route of E. histolytica is ingestion of drinking water or food contaminated with human feces (6, 7). In addition, E. histolytica has been responsible of water-associated outbreaks of the disease (8). Sexually transmitted infections with E. histolytica have also been reported (9, 10). Most infections with E. histolytica are asymptomatic, and infected individuals become parasite carriers (2). However, some individuals may develop a severe disease with hemorrhagic colitis and extra-intestinal disease (11). An important number of travelers suffering from prolonged diarrhea were infected with E. histolytica (12, 13). Furthermore, E. histolytica is responsible for the development of life-threatening abscesses in organs including liver, brain (14, 15) and lungs (16). Diagnosis of E. histolytica infection is based on a combination of serological tests with antigen detection by immunoassays or detection of parasite DNA by polymerase chain reaction (11).

Amebiasis, the disease caused by E. histolytica, is recognized as a major source of morbidity and mortality in the developing world (5). However, very little is known about the magnitude of infection with E. histolytica in Mexico. In a national serosurvey in this country, researchers found a low (4.49%) seroprevalence of E. histolytica infection (17). However, in a recent study in rural population in the northern Mexican state of Durango, researchers found a high (41.8%) seroprevalence of E. histolytica infection (18). The seroepidemiology of E. histolytica infection in different ethnic groups in Mexico is largely unknown. Tepehuanos is an indigenous ethnic group living in remote mountainous regions in northern Mexico. They live in poverty in rural areas with poor housing conditions and sanitation. These factors may favor transmission of waterborne and foodborne infections among this population including E. histolytica infection. In addition, Tepehuanos have limited access to health care facilities and laboratory tests for the diagnosis of E. histolytica infection. There are currently no statistics about the magnitude of E. histolytica infection in Tepehuanos. This study aimed to determine the seroprevalence of E. histolytica IgG antibodies in Tepehuanos population in Durango, Mexico. Furthermore, we sought to determine the socio-demographic, clinical, and behavioral characteristics of the Tepehuanos associated with E. histolytica seropositivity.

METHODS

Selection and description of the participants

We performed a cross-sectional survey using stored serum samples from a previous study on seroepidemiology of Toxoplasma gondii infection in Tepehuanos in Durango, Mexico (19). Serum samples were collected between January 2010 and March 2011. Inclusion criteria for enrollment of the study subjects were: 1) People of Tepehuano ethnicity (indigenous people who speak the Tepehuano language, and identify themselves as Tepehuanos), 2) aged 15 years and older, and 3) who voluntarily accepted to participate in the study, regardless of gender, occupation and socioeconomic status. Exclusion criteria for enrollment of Tepehuanos were: 1) individuals with insufficient amount of serum; and 2) individuals with incomplete epidemiological data. In total, of 180 Tepehuano people invited, 156 agreed to participate in the study.

General socio-demographic, clinical, and behavioral characteristics of Tepehuanos

We used a standardized questionnaire to obtain the socio-demographic, clinical and behavioral characteristics of the Tepehuanos. A face-to-face interview was conducted to obtain the characteristics of the Tepehuanos. Socio-demographic data including age, birthplace, residence area, educational level, socio-economic status, and employment from all participants were obtained. Classification of socio-economic levels in Tepehuanos was based on their own perception of wealth. Clinical data included health status, presence of gastrointestinal complaints, frequent headache (occurring at least 3 days a week), and history of lymphadenopathy or surgery. Clinical data included in the analysis were those reported by Tepehuanos, and no specific tests to confirm diagnoses were performed. Tepehuanos were asked whether they were aware of suffering from any disease. A Tepehuano was considered as ill when he or she self-reported suffering from any disease either with or without current presence of symptoms. Comorbidities referred by Tepehuanos were diverse and included asthma, diabetes, convulsions, flu, tonsillitis, colitis, cholecystitis and others. Behavioral data included consumption of untreated water or unpasteurized milk, consumption of unwashed raw vegetables or fruits, frequency of eating away from home (in restaurants or fast food outlets), raising farm animals (chickens, cows, horses, goats, or sheep), foreign travel, contact with soil (gardening or agriculture in a regular basis), and type of flooring at home.

Technical information

Serum samples of Tepehuanos were analyzed for anti- E. histolytica IgG antibodies by a commercially available enzyme immunoassay “E. histolytica IgG (Amebiasis) ELISA” kit (Diagnostic Automation Inc., Calabasas, CA). According to the kit’s insert, this enzyme immunoassay has a sensitivity of 92% and a specificity of 100%. All assays were performed following the instructions of the manufacturer. Positive and negative controls were run in each assay. We are not aware of further epidemiological studies that had used this kit. Low antibody levels were considered when optical densities between 0.3 to 0.9 were obtained. Whereas, high antibody levels were considered when optical densities higher than 0.9 were obtained.

Statistics

Results were analyzed with the aid of the software Epi Info version 7 and SPSS version 15.0. We used the Pearson’s Chi-square test and the Fisher exact test, if assumptions for Chi-square test were not met, for descriptive analysis for this study. Multivariate analysis was used to determine the association of E. histolytica seropositivity with socio-demographic, clinical, and behavioral characteristics of Tepehuanos. As a criterion to include variables in the multivariate analysis only variables with a p≤0.15 obtained in the bivariate analysis were considered. We calculated the odds ratios (OR) and 95% confidence intervals (CI) by using logistic regression analysis. A p<0.05 was considered as statistically significant.

Ethical aspects

In the present study, we used only archival serum samples and data from a previous study (17). The ethics committee of the General Hospital of the Secretary of Health in Durango City, Mexico has approved the previous study. The purpose and procedures of the survey were explained to all Tepehuanos, and a written informed consent was obtained from all of them. In addition, the ethics committee of the Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado in Durango City approved this project.

RESULTS

Of the 156 Tepehuanos, 88 were female (56.4%) and 68 were male (43.6%). Mean age of participants was 31.03 ± 16.71 years old, ranging between 15 and 89 years. Forty-four (28.2%) Tepehuanos had anti- E. histolytica IgG antibodies. Of these 44 Tepehuanos, 30 (68.2%) had low anti-E. histolytica antibody levels and 14 (31.8%) had high anti-E. histolytica antibody levels. Socio-demographic characteristics of Tepehuanos and their association with E. histolytica seropositivity is shown in Table 1. The variables age and occupation were the only socio-demographic characteristics associated with E. histolytica exposure by bivariate analysis. Seroprevalence of E. histolytica exposure was higher in laborers than in non-laborers. The frequency of E. histolytica exposure was similar among individual occupations.

Table 1.

Socio-demographic characteristics of Tepehuanos and seroprevalence of E. histolytica infection

Characteristic No. of subjects testeda Prevalence of E. histolytica infection
p value
No. %

Gender
  Male 68 23 33.8 0.17
  Female 88 21 23.9  
Age groups (years)
  20 or less 61 8 13.1 0.003
  21-30 38 13 34.2  
  31-50 31 15 48.4  
  >50 25 8 32.0  
Birth place
  Durango State 153 44 28.8 1
  Other Mexican State 2 0 0.0  
Residence area
  Urban 13 2 23.1 0.75
  Rural 141 41 29.1  
Educational level
  No education 43 12 27.9 0.52
  1-6 years 31 11 35.5  
  7 or more years 81 20 24.7  
Occupation
  Laborerb 68 25 36.8 0.03
  Nonlaborerc 88 19 21.6  
Socio-economic level
  Low 147 42 28.6 1
  Medium 8 2 25.0  
a

Subjects with available data;

b

Agriculture, employee, construction worker, business, factory worker, other;

c

Housewife or student.

Of the clinical characteristics, only the variables ill status and lymphadenopathy had likely association (p≤0.15) with E. histolytica exposure by bivariate analysis. Clinical characteristics and a selection of behavioral data of Tepehuanos and their relation with E. histolytica seropositivity are shown in Table 2. Of the behavioral data, only the variables raising animals, frequency of eating out of home, consumption of unwashed raw fruits, and soil contact had likely associations (p values ≤ 0.15) with E. histolytica exposure by bivariate analysis. Results of the multivariate analysis are shown in Table 3. Logistic regression analyses showed that E. histolytica exposure was positively associated with laborer occupation (OR=2.77; 95% CI: 1.15, 6.66; p=0.02), and history of lymphadenopathy (OR=4.97; 95% CI: 1.74, 14.13; p=0.002). In addition, E. histolytica exposure was negatively associated with soil contact (OR=0.13; 95% CI: 0.03, 0.53; p=0.004).

Table 2.

Bivariate analysis of clinical and behavioral data and infection with E. histolytica in Tepehuanos in Durango, Mexico

Characteristic No. of Subjects testeda Seroprevalence of E. histolytica infection
p value
No. %

Clinical status
  Healthy 107 25 23.4 0.08
  Ill 46 17 37  
Gastrointestinal complaints
  Yes 9 1 11.1 0.44
  No 147 43 29.3  
Lymphadenopathy ever
  Yes 26 14 53.8 0.001
  No 130 30 23.1  
Headache frequently
  Yes 65 18 27.7 0.9
  No 91 26 28.6  
Surgery ever
  Yes 27 7 25.9 0.77
  No 129 37 28.7  
Raising animals
  Yes 130 33 25.4 0.08
  No 26 11 42.3  
Eating out of home
  Never 33 14 42.4 0.07
  From 1 to 10 times a year 99 22 22.2  
  More than 10 times a year 22 7 31.8  
Unwashed raw fruits
  Yes 85 28 32.9 0.11
  No 70 15 21.4  
Untreated water
  Yes 128 36 28.1 0.81
  No 27 7 25.9  
Soil contact
  Yes 142 35 24.6 0.008
  No 13 8 61.5  
Floor at home
  Ceramic 21 4 19 0.54
  Concrete 57 18 31.6  
  Soil 77 21 27.3  
a

Participants with available data.

Table 3.

Multivariate analysis of selected characteristics of Tepehuanos and their association with E. histolytica infection

Characteristic Odds ratio 95% confidence interval p value

Age 1.07 0.57-2.01 0.8
Laborer 2.77 1.15-6.66 0.02
Raising animals 0.42 0.14-1.22 0.11
Eating out of home 0.93 0.47-1.84 0.84
Unwashed raw fruit consumption 1.41 0.58-3.39 0.43
Soil contact 0.13 0.03-0.53 0.004
Lymphadenopathy 4.97 1.74-14.13 0.002
Ill status 1.07 0.39-2.92 0.89

DISCUSSION

There is a lack of knowledge about the seroepidemiology of E. histolytica infection in ethnic groups in Mexico. Tepehuanos is the most numerous indigenous ethnic group in Durango, Mexico. Therefore, in this study we sought to determine the seroprevalence and correlates of E. histolytica exposure in Tepehuanos in the northern Mexican state of Durango.

With respect to seroprevalence, we found a 28.2% seroprevalence of E. histolytica infection in Tepehuanos. Remarkably, this E. histolytica seroprevalence is higher than other reported E. histolytica seroprevalences in Mexican populations. For instance, a low (<5%) seroprevalence of E. histolytica was found in a survey in populations living in northern Mexican states (20). However, this previous study was performed about 25 years ago. It is possible that seroprevalence had increased lately. However, interpretation of this comparison should be taken with care since different laboratory tests were used among the studies. A homemade ELISA with 95% sensitivity and 90.7% specificity was used in the previous study (20), whereas a commercially available ELISA with 92% sensitivity and 100% specificity was used in the present study. The seroprevalence found in Tepehuanos is also higher that the 5.95% seroprevalence found in a national survey in 1974 by using counter-current immunoelectrophoresis (21). In addition, the seroprevalence found in Tepehuanos is higher than the 8.41% and 4.49% seroprevalences of E. histolytica infection reported in 2 more national surveys reported in the year 1994 by using indirect hemagglutination test (22) and in the year 1995 by using a home-made ELISA (17), respectively. Again, laboratory tests used in the national surveys were different from the commercially available test we used, and comparison of the seroprevalences among the studies should be interpreted with care. It is likely that difference in environment may explain the higher seroprevalence of E. histolytica infection in Tepehuanos than in other populations studied in Mexico. Tepehuanos live in rural areas and have a number of contributing factors for infectious diseases as waterborne and foodborne infections. Many Tepehuanos live in poverty, have low education, and suffer from bad nutrition. Their communities have poor sanitation, low housing conditions including poor access to potable water, and lack of sewage systems. The seroprevalence found in Tepehuanos is slightly lower than the 41.8% seroprevalence of E. histolytica exposure in general population in rural Durango, Mexico (18). Differences in socio-demographic characteristics of the populations among the studies might explain the difference in the seroprevalence. For instance, the mean age in Tepehuanos was 31.03 years whereas the mean age in general population was 42.91 years (18).

Concerning correlates of E. histolytica exposure, a number of contributing factors for E. histolytica infection were assessed in the present study. Multivariate analysis of socio-demographic, clinical and behavioral characteristics of Tepehuanos potentially associated with infection by bivariate analysis showed that E. histolytica exposure was positively associated with laborer occupation and history of lymphadenopathy, and negatively associated with soil contact. Tepehuanos who worked had a higher seroprevalence of E. histolytica infection than subjects who did not work. This finding might suggest that infection was more likely acquired out of home. It is possible that poorer hygiene practices and sanitation existed at their work place than at home. Intriguingly, seroprevalence of E. histolytica was higher in Tepehuanos with a history of lymphadenopathy than in those without this history. Lymphadenopathy associated with E. histolytica infection has been scantily reported. A case of inguinal necrotizing lymphadenitis caused by E. histolytica was reported in the USA (23). General lymphadenopathy in a patient with protracted course of amebic liver abscess, amebic colitis, and fever was reported in Taiwan (24). Infection with E. histolytica was linked to the Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis) in a patient in Turkey (25). The association of E. histolytica seropositivity and lymphadenopathy found in the present study deserves further investigation. On the other hand, the negative association of E. histolytica exposure with soil contact suggest that this factor did not play any contributing role for E. histolytica infection among Tepehuanos. We are not aware of further reports about the seroprevalence of E. histolytica among ethnic groups. Our seroprevalence results can be a baseline for further research of E. histolytica exposure in ethnic groups. In a recent study of general population in rural Durango, Mexico, exposure to E. histolytica was associated with housing conditions including source of drinking water and poor education of the head of the family (18). However, these factors were not evaluated in the present study and further research to determine the association of E. histolytica exposure with housing conditions of Tepehuanos is needed.

With regard to limitations of the study, the present study has some limitations including a small sample size and limited clinical information. The small size of occupation subsets did not allow us to perform a fairly comparison among individual occupations.

CONCLUSIONS

We conclude that the seroprevalence of E. histolytica exposure in Tepehuanos is higher than E. histolytica seroprevalences reported in national surveys. The factors associated with E. histolytica seropositivity found in the present study could be useful for the planning of optimal preventive measures against E. histolytica infection.

ACKNOWLEDGEMENTS

This study was financially supported by Juárez University of Durango State, Durango, Mexico. The original work of toxoplasmosis was financially supported by Consejo de Ciencia y Tecnología, Mexico.

CONFLICT OF INTEREST

Authors declare that they have no conflict of interest.

REFERENCES

  • 1.Bercu TE, Petri WA, Behm JW. Amebic colitis: new insights into pathogenesis and treatment. Curr. Gastroenterol Rep. 2007;9(5):429. doi: 10.1007/s11894-007-0054-8. [DOI] [PubMed] [Google Scholar]
  • 2.Nair GV, Variyam EP. Noninvasive intestinal amebiasis: Entamoeba histolytica colonization without invasion. Curr. Opin. Infect. Dis. 2014;27(5):465. doi: 10.1097/QCO.0000000000000095. [DOI] [PubMed] [Google Scholar]
  • 3.Choudhuri G, Rangan M. Amebic infection in humans. Indian J. Gastroenterol. 2012;31(4):153. doi: 10.1007/s12664-012-0192-2. [DOI] [PubMed] [Google Scholar]
  • 4.Mortimer L, Chadee K. The immunopathogenesis of Entamoeba histolytica . Exp. Parasitol. 2000;126(3):366. doi: 10.1016/j.exppara.2010.03.005. [DOI] [PubMed] [Google Scholar]
  • 5.Ralston KS, Petri WA., Jr Tissue destruction and invasion by Entamoeba histolytica . Trends Parasitol. 2011;27(6):254. doi: 10.1016/j.pt.2011.02.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Bouzid M, Steverding D, Tyler KM. Detection and surveillance of waterborne protozoan parasites. Curr. Opin. Biotechnol. 2008;19(3):302. doi: 10.1016/j.copbio.2008.05.002. [DOI] [PubMed] [Google Scholar]
  • 7.Marie C, Petri WA., Jr Amoebic dysentery. Clin. Evid. (Online) 2013;2013:918. [PMC free article] [PubMed] [Google Scholar]
  • 8.Karanis P, Kourenti C, Smith H. Waterborne transmission of protozoan parasites: a worldwide review of outbreaks and lessons learnt. J. Water Health. 2007;5(1):1. doi: 10.2166/wh.2006.002. [DOI] [PubMed] [Google Scholar]
  • 9.Hung CC, Chang SY, Ji DD. Entamoeba histolytica infection in men who have sex with men. Lancet Infect Dis. 2012;12(9):729. doi: 10.1016/S1473-3099(12)70147-0. [DOI] [PubMed] [Google Scholar]
  • 10.Showler AJ, Boggild AK. Entamoeba histolytica. CMAJ. 2013;185(12):1064. doi: 10.1503/cmaj.121576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Chacín-Bonilla L. An update on amebiasis. Rev. Med. Chil. 2013;141(5):609. doi: 10.4067/S0034-98872013000500009. [DOI] [PubMed] [Google Scholar]
  • 12.Cavallo JD, Garrabé E. Infectious aetiologies of travelers´ diarrhoea. Med. Mal. Infect. 2007;37(11):722. doi: 10.1016/j.medmal.2007.09.004. [DOI] [PubMed] [Google Scholar]
  • 13.Slack A. Parasitic causes of prolonged diarrhoea in travellers - diagnosis and management. Aust. Fam. Physician. 2012;41(10):782. [PubMed] [Google Scholar]
  • 14.Wuerz T, Kane JB, Boggild AK, et al. A review of amoebic liver abscess for clinicians in a nonendemic setting. Can. J. Gastroenterol. 2012;26(10):729. doi: 10.1155/2012/852835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Petri WA, Haque R. Entamoeba histolytica brain abscess. Handb Clin. Neurol. 2013;114:147. doi: 10.1016/B978-0-444-53490-3.00009-1. [DOI] [PubMed] [Google Scholar]
  • 16.Tengku SA, Norhayati M. Public health and clinical importance of amoebiasis in Malaysia: a review. Trop. Biomed. 2011;28(2):194. [PubMed] [Google Scholar]
  • 17.González CR, Isibasi A, Ortiz-Navarrete V, et al. Prevalence of antibodies against Entamoeba histolytica in Mexico measured by ELISA. Epidemiol Infect. 1995;115(3):535. doi: 10.1017/s0950268800058702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Alvarado-Esquivel C, Hernandez-Tinoco J, Sanchez-Anguiano LF. Seroepidemiology of Entamoeba histolytica Infection in General Population in Rural Durango, Mexico. J. Clin. Med. Res. 2015;7(6):435–439. doi: 10.14740/jocmr2131w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Alvarado-Esquivel C, Estrada-Martínez S, García-López CR, et al. Seroepidemiology of Toxoplasma gondii infection in Tepehuanos in Durango, Mexico. Vector Borne Zoonotic Dis. 2012;12(2):138. doi: 10.1089/vbz.2011.0747. [DOI] [PubMed] [Google Scholar]
  • 20.Isibasi A, González C, Ortíz V, et al. Seroepidemiology of amebiasis in the northern region of the Republic of Mexico. Arch. Invest. Med. (Mex) 1990;21 Suppl 1:163. [PubMed] [Google Scholar]
  • 21.Gutiérrez G, Ludlow A, Espinoza G, et al. Antibodies against Entamoeba histolytica in the Mexican Republic. 1974. Salud Publica Mex. 1992;34(2):242. [PubMed] [Google Scholar]
  • 22.Caballero-Salcedo A, Viveros-Rogel M, Salvatierra B, et al. Seroepidemiology of amebiasis in Mexico. Am. J. Trop. Med. Hyg. 1994;50(4):412. doi: 10.4269/ajtmh.1994.50.412. [DOI] [PubMed] [Google Scholar]
  • 23.Mayhew KM, Dundoo M, Dunne EF, Dwinnell BG, et al. Inguinal lymphadenitis caused by Entamoeba histolytica: case report and literature review. Mayo Clin. Proc. 2000;75(5):513. doi: 10.4065/75.5.513. [DOI] [PubMed] [Google Scholar]
  • 24.Liu CJ, Hung CC, Chen MY, et al. Amebic liver abscess and human immunodeficiency virus infection: a report of three cases. J. Clin. Gastroenterol. 2001;33(1):64. doi: 10.1097/00004836-200107000-00016. [DOI] [PubMed] [Google Scholar]
  • 25.Aydogan T, Kanbay M, Uraldi C, et al. Kikuchi Fujimoto disease secondary to Entamoeba histolytica: case report. J. Infect. 2006;53(4):e171–173. doi: 10.1016/j.jinf.2005.12.007. [DOI] [PubMed] [Google Scholar]

Articles from International Journal of Biomedical Science : IJBS are provided here courtesy of Master Publishing Group

RESOURCES